NeoGenomics, Inc. recently announced that its PanTracer LBx liquid biopsy test has received Medicare coverage under the MolDX Plasma-Based Genomic Profiling in Solid Tumors policy, allowing eligible ...
NeoGenomics' PanTracer™ LBx test has received coverage from the Centers for Medicare & Medicaid Services’ Molecular ...
Medicare will now cover tests that screen for multiple types of cancer at once, under a new bipartisan law backed by Georgia ...
The program may soon provide broader coverage to improve retirees' health.
The Medicare coverage you choose determines how much money you pay out of pocket for medical care during retirement, which medical providers can give you fully covered care, and other results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results